High-dose Aumolertinib as First-line Treatment in Patients With Brain Metastases Associated With EGFR Mutated NSCLC
文献类型：期刊论文
| 作者 | Fan, Y. |
| 刊名 | JOURNAL OF THORACIC ONCOLOGY
 |
| 出版日期 | 2022-09-01 |
| 卷号 | 17 |
| 关键词 | NSCLC EGFR TKI Brain Metastases |
| ISSN号 | 1556-0864 |
| WOS研究方向 | Oncology ; Respiratory System |
| 语种 | 英语 |
| WOS记录号 | WOS:000858678101180 |
| 出版者 | ELSEVIER SCIENCE INC |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129809]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | Univ Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China |
| 推荐引用方式 GB/T 7714 | Fan, Y.. High-dose Aumolertinib as First-line Treatment in Patients With Brain Metastases Associated With EGFR Mutated NSCLC[J]. JOURNAL OF THORACIC ONCOLOGY,2022,17. |
| APA | Fan, Y..(2022).High-dose Aumolertinib as First-line Treatment in Patients With Brain Metastases Associated With EGFR Mutated NSCLC.JOURNAL OF THORACIC ONCOLOGY,17. |
| MLA | Fan, Y.."High-dose Aumolertinib as First-line Treatment in Patients With Brain Metastases Associated With EGFR Mutated NSCLC".JOURNAL OF THORACIC ONCOLOGY 17(2022). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。